Hyouk-Soo Kwon1, Tae-Bum Kim1, Yoon Su Lee1, Seung-Hwan Jeong2, Yun-Jeong Bae3, Keun-Ai Moon4, Bo-Ram Bang4, Hee-Bom Moon1, You Sook Cho5. 1. Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. 2. Department of Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea. 3. Asan Medical Center, Health Screening and Promotion Center, Seoul, Republic of Korea. 4. Asan Institute of Life Science, Seoul, Republic of Korea. 5. Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: yscho@amc.seoul.kr.
Abstract
BACKGROUND: Oxidative stress is thought to play a role in the pathogenesis of asthma. Clusterin is a sensitive cellular biosensor of oxidative stress and has antioxidant properties. The function and expression of clusterin in patients with asthma have not been fully investigated. OBJECTIVE: To investigate whether the expression of clusterin in patients with asthma is regulated by increased oxidative burden and whether clusterin expression could be used to assess the response to inhaled corticosteroids. METHODS: Clusterin levels in serum, induced sputum, and peripheral blood mononuclear cells of patients with asthma were measured by enzyme-linked immunosorbent assay and western blotting and compared with pulmonary function and levels of expression of hyperoxidized peroxiredoxins. Serum concentrations of clusterin in treatment-naive patients were compared before and after inhaled corticosteroid use. RESULTS: Serum clusterin concentration was significantly elevated in patients with severe asthma and was inversely correlated with pulmonary function. The expression of hyperoxidized peroxiredoxins was greatly increased in peripheral blood mononuclear cells of patients with asthma and was strongly correlated with clusterin expression. Serum clusterin concentrations in treatment-naive patients with asthma were decreased significantly after initial treatment with inhaled corticosteroids. CONCLUSION: Clusterin may be a biomarker of asthma severity and the burden of oxidative stress in patients with asthma. Moreover, clusterin may be useful for the prompt assessment of airway inflammation.
BACKGROUND: Oxidative stress is thought to play a role in the pathogenesis of asthma. Clusterin is a sensitive cellular biosensor of oxidative stress and has antioxidant properties. The function and expression of clusterin in patients with asthma have not been fully investigated. OBJECTIVE: To investigate whether the expression of clusterin in patients with asthma is regulated by increased oxidative burden and whether clusterin expression could be used to assess the response to inhaled corticosteroids. METHODS:Clusterin levels in serum, induced sputum, and peripheral blood mononuclear cells of patients with asthma were measured by enzyme-linked immunosorbent assay and western blotting and compared with pulmonary function and levels of expression of hyperoxidized peroxiredoxins. Serum concentrations of clusterin in treatment-naive patients were compared before and after inhaled corticosteroid use. RESULTS: Serum clusterin concentration was significantly elevated in patients with severe asthma and was inversely correlated with pulmonary function. The expression of hyperoxidized peroxiredoxins was greatly increased in peripheral blood mononuclear cells of patients with asthma and was strongly correlated with clusterin expression. Serum clusterin concentrations in treatment-naive patients with asthma were decreased significantly after initial treatment with inhaled corticosteroids. CONCLUSION:Clusterin may be a biomarker of asthma severity and the burden of oxidative stress in patients with asthma. Moreover, clusterin may be useful for the prompt assessment of airway inflammation.
Authors: Jeremy D Furtado; Rain Yamamoto; John T Melchior; Allison B Andraski; Maria Gamez-Guerrero; Patrick Mulcahy; Zeling He; Tianxi Cai; W Sean Davidson; Frank M Sacks Journal: Arterioscler Thromb Vasc Biol Date: 2018-12 Impact factor: 8.311
Authors: David M Habiel; Ana Camelo; Milena Espindola; Timothy Burwell; Richard Hanna; Elena Miranda; Alan Carruthers; Matthew Bell; Ana Lucia Coelho; Hao Liu; Fernanda Pilataxi; Lori Clarke; Ethan Grant; Arthur Lewis; Bethany Moore; Darryl A Knight; Cory M Hogaboam; Lynne A Murray Journal: Sci Rep Date: 2017-11-13 Impact factor: 4.379
Authors: Jessica Balena-Borneman; Namasivayam Ambalavanan; Hemant K Tiwari; Russell L Griffin; Brian Halloran; David Askenazi Journal: Pediatr Res Date: 2016-11-28 Impact factor: 3.756
Authors: Brigitta Dombai; István Ivancsó; András Bikov; Dóra Oroszi; Anikó Bohács; Veronika Müller; János Rigó; Barna Vásárhelyi; György Losonczy; Lilla Tamási Journal: Can Respir J Date: 2017-10-23 Impact factor: 2.409